首页> 外国专利> Heterologous prime boost vaccination regimen against malaria

Heterologous prime boost vaccination regimen against malaria

机译:异源抗疟疾初免疫苗接种方案

摘要

Described are methods for inducing an immune response in a subject against an antigen from a malaria-causing parasite, preferably P. falciparum, the method comprising: (i) administering to a subject a priming composition comprising adjuvanted proteinaceous antigen-comprising circumsporozoite (CS) protein or an immunogenic part thereof from a malaria-causing parasite; (ii) administering to the subject a first boosting composition comprising a recombinant adenovirus vector that comprises nucleic acid encoding CS protein or immunogenic part thereof from a malaria-causing parasite; and (iii) administering to the subject a second boosting composition comprising a recombinant adenovirus vector that comprises nucleic acid encoding CS protein or an immunogenic part thereof from a malaria-causing parasite, wherein either the first boosting composition comprises a recombinant adenovirus vector of serotype 35 (Ad35) and the second boosting composition comprises a recombinant adenovirus of Ad26, or wherein the first boosting composition comprises a recombinant adenovirus vector of Ad26 and the second boosting composition comprises a recombinant adenovirus of Ad35.
机译:描述了用于诱导受试者针对来自引起疟疾的寄生虫,优选地I P的抗原的免疫应答的方法。恶性疟原虫,该方法包括:(i)向受试者施用引发组合物,该引发组合物包含来自引起疟疾的寄生虫的佐剂化的含蛋白质抗原的环子孢子(CS)蛋白或其免疫原性部分; (ii)向受试者施用第一加强组合物,其包含重组腺病毒载体,该重组腺病毒载体包含来自引起疟疾的寄生虫的编码CS蛋白或其免疫原性部分的核酸; (iii)向所述受试者施用第二加强组合物,所述第二加强组合物包含重组腺病毒载体,所述重组腺病毒载体包含编码来自引起疟疾的寄生虫的CS蛋白或其免疫原性部分的核酸,其中所述第一加强组合物包含血清型35的重组腺病毒载体(Ad35)和第二加强组合物包含Ad26的重组腺病毒,或者其中第一加强组合物包含Ad26的重组腺病毒载体,第二加强组合物包括Ad35的重组腺病毒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号